Walking is something most people do without thinking. The brain automatically coordinates movements of the legs, balance, and timing of each step.
For people with Parkinson’s disease, however, walking can become one of the most difficult parts of daily life.
Many patients shuffle their feet, lose balance, or suddenly freeze in place. Falls become more common, and simple activities such as shopping, going outside, or moving around the house can become stressful and frightening.
Parkinson’s disease affects millions of people around the world. The condition develops when nerve cells in the brain gradually stop producing enough dopamine, a chemical messenger that helps control movement.
As dopamine levels fall, people may develop tremors, muscle stiffness, slowness of movement, and difficulties with coordination and balance.
One of the most advanced treatments for Parkinson’s disease is deep brain stimulation. This treatment involves placing electrodes in specific regions of the brain and connecting them to a battery-powered device implanted under the skin.
The system sends electrical pulses to help regulate abnormal brain activity. Deep brain stimulation has helped many people manage tremors and other movement problems. Yet walking difficulties often remain one of the hardest symptoms to treat.
Researchers at the University of California, San Francisco wanted to know whether brain stimulation could become smarter. Instead of delivering the same electrical signals continuously, they wondered if a device could monitor brain activity and respond immediately to changes in movement.
Their study, published in Nature Medicine, provides early evidence that this may be possible. The researchers created a personalized adaptive deep brain stimulation system that can recognize brain signals linked to movement of the left and right legs. The implanted device then changes its stimulation within fractions of a second as the person walks.
The scientists describe the technology as similar to a cardiac pacemaker. A heart pacemaker monitors the heart and responds when its rhythm changes. In a similar way, the new brain device listens to signals associated with walking and adjusts treatment accordingly.
Five people with Parkinson’s disease participated in the study. All had previously undergone deep brain stimulation surgery. The participants also received research electrodes over movement-related regions of the brain.
This allowed scientists to identify each participant’s unique brain activity patterns and teach the implanted device how to respond during walking.
The participants first underwent testing in the laboratory. When the adaptive system was active, their walking became more balanced and more regular. The researchers then evaluated the participants during everyday life in a blinded study lasting several days.
The results were encouraging. Participants experienced fewer falls when the adaptive stimulation was active. Importantly, the system continued to control other Parkinson’s symptoms effectively, and no serious adverse events occurred. Patients also tolerated the rapid changes in stimulation without major problems.
The findings suggest that timing may be an important part of successful brain stimulation therapy. Instead of providing constant stimulation regardless of activity, future devices may deliver treatment only when needed and precisely match a person’s behavior.
The implications extend beyond walking. Researchers believe similar technology could eventually be developed for other functions controlled by the brain, including speech, mood, memory, and thinking. Future devices may continuously monitor brain activity and respond automatically to changes in a patient’s condition.
The study does have important limitations. Only five people participated, making it impossible to know whether the results apply to everyone with Parkinson’s disease. The follow-up period was also relatively short. Larger and longer studies will be needed before the technology can become widely available.
Even so, this research represents a major advance in personalized medicine. Its greatest strength is the demonstration that implanted brain devices can react to behavior in real time.
Although much work remains, the study offers hope that future brain therapies may become far more intelligent and responsive than current treatments. For people living with Parkinson’s disease, this could eventually mean safer walking, fewer falls, and greater independence in daily life.
If you care about Parkinson’s disease, please read studies that Vitamin B may slow down cognitive decline, and Mediterranean diet could help lower risk of Parkinson’s.
For more health information, please see recent studies about how wheat gluten might be influencing our brain health, and Olive oil: a daily dose for better brain health..
Source: University of California, San Francisco.
